Enroll-HD as a robust external control database
The case was made that the Enroll-HD database, with over 33,000 participants tracked for a decade, provides a sufficiently robust external control arm for evaluating Huntington's disease therapies, potentially obviating the need for a traditional placebo group.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.